Biofrontera Inc. (NASDAQ:BFRIW) Sees Significant Increase in Short Interest

Biofrontera Inc. (NASDAQ:BFRIW) saw a large growth in short interest in August. As of August 31st, there was short interest totaling 5,274 shares, a growth of 77.3% from the August 15th total of 2,975 shares. Based on an average daily trading volume, of 2,250 shares, the days-to-cover ratio is currently 2.3 days.

Biofrontera Stock Performance

BFRIW remained flat at $0.02 during midday trading on Wednesday. 264 shares of the company’s stock traded hands, compared to its average volume of 5,962. The firm has a 50 day moving average of $0.03 and a 200-day moving average of $0.03. Biofrontera has a 1-year low of $0.02 and a 1-year high of $0.15.

About Biofrontera

Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.

The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.